New Key Statistics Module, Z-Score and F-Score
OTCPK:SFOSF Key Ratios
Market Cap $ M | 8,455.34 |
Enterprise Value $ M | 12,707.42 |
P/E(ttm) | 32.82 |
PE Ratio without NRI | 21.84 |
Forward PE Ratio | 9.94 |
Price/Book | 1.45 |
Price/Sales | 1.66 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.24 |
Revenue (TTM) $ M | 5,806.00 |
EPS (TTM) $ | 0.11 |
Beneish M-Score | -2.43 |
10-y EBITDA Growth Rate % | 8.20 |
5-y EBITDA Growth Rate % | 4.30 |
y-y EBITDA Growth Rate % | -21.90 |
EV-to-EBIT | 20.60 |
EV-to-EBITDA | 20.60 |
PEG | 5.08 |
Shares Outstanding M | 2,671.33 |
Net Margin (%) | 5.08 |
Operating Margin % | 6.61 |
Pre-tax Margin (%) | 7.32 |
Quick Ratio | 0.72 |
Current Ratio | 0.92 |
ROA % (ttm) | 1.86 |
ROE % (ttm) | 4.55 |
ROIC % (ttm) | 2.44 |
Dividend Yield % | 2.16 |
Altman Z-Score | 1.43 |
SFOSF Number of Guru Trades
SFOSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SFOSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SFOSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
No Available Data
News about OTCPK:SFOSF
Total 0- 1